title: Cilostazol: a drug particularly effective for Asians?
abstract: Cilostazol is an antiplatelet drug often used in Asia; however, it is rarely used in the western hemisphere, particularly for stroke patients. Further studies of cilostazol in other ethnicities are required to prove or disprove whether this drug is also beneficial in non-Asian populations.
authors.affiliation: Stroke Center and Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. jongskim@amc.seoul.kr
authors.forename: Jong S
authors.initials: JS
authors.lastname: Kim
authors.forename: Yukito
authors.initials: Y
authors.lastname: Shinohara
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D044466:Asian People; D001241:Aspirin / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000150:complications / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D000077407:Cilostazol; D065731:Cytochrome P-450 CYP2C19; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D010597:Pharmacogenetics; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D000077407:Cilostazol; D001241:Aspirin